2011-1992. Advisory Committees; Filing of Closed Meeting Reports  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that, as required by the Federal Advisory Committee Act, the Agency has filed with the Library of Congress the annual reports of those FDA advisory committees that held closed meetings during fiscal year 2010.

    ADDRESSES:

    Copies are available from the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852, 301-827-6860.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Teresa L. Hays, Committee Management Officer, Advisory Committee and Oversight Management Staff, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 32, rm. 5290, Silver Spring, MD 20993-0002, 301-796-8220.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    Under section 10(d) of the Federal Advisory Committee Act (5 U.S.C. app.1) and 21 CFR 14.60(d), FDA has filed with the Library of Congress the annual reports for the following FDA advisory committees that held closed meetings during the period October 1, 2009, through September 30, 2010:

    Center for Biologics Evaluation and Research:

    Blood Products Advisory Committee,

    Vaccines and Related Biological Products Advisory Committee.

    National Center for Toxicological Research:

    Science Board to the National Center for Toxicological Research.

    Annual reports are available for public inspections between 9 a.m. and 4 p.m., Monday through Friday at the following locations:

    1. The Library of Congress, Madison Bldg., Newspaper and Current Periodical Reading Room, 101 Independence Ave., SE., rm. 133, Washington, DC; and

    2. The Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.

    Start Signature

    Dated: January 26, 2011.

    Jill Hartzler Warner,

    Acting Associate Commissioner for Special Medical Programs.

    End Signature End Supplemental Information

    [FR Doc. 2011-1992 Filed 1-28-11; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Published:
01/31/2011
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2011-1992
Pages:
5380-5380 (1 pages)
Docket Numbers:
Docket No. FDA 2011-N-0002
PDF File:
2011-1992.pdf